Human Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG-IgG) (BSIG-H343)

Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-Kit and anti-VCAM-1 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget hematopoietic stem cells to injured myocardium. It is designed for the research of Cardiovascular disease therapy.

Datasheet INQUIRY

Specifications

Targets

Kit & VCAM-1

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Cardiovascular disease

Targets

Target 1

Kit

Gene ID

3815

UniProt ID

A0A024RDA0

Alternative Names

W; Bs; Fdc; Ssm; SCO1; SCO5; SOW3; CD117; c-KIT; Tr-kit; Gsfsco1; Gsfsco5; Gsfsow3; KIT proto-oncogene receptor tyrosine kinase; KIT

Target 2

VCAM-1

Gene ID

7412

UniProt ID

P19320

Alternative Names

CD106, INCAM-100; Vascular cell adhesion molecule-1; VCAM-1; vascular cell adhesion protein 1

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Human Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG-IgG) (BSIG-H343). Click the button below to contact us or submit your feedback about this product.

Human Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H343)

Specifications

Targets

Customer Reviews and Q&As